MedPath

Comparative Effectiveness of Readmission Reduction Interventions for Individuals with Sepsis or Pneumonia

Not Applicable
Completed
Conditions
Lower Resp Tract Infection
Sepsis
Pneumonia
Covid19
Registration Number
NCT04829188
Lead Sponsor
University of Pittsburgh
Brief Summary

An adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospitalized with sepsis or lower respiratory tract infection. The primary outcome is number of days spent at home within 90 days after hospital discharge.

Detailed Description

This study implements an adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospitalized with sepsis or lower respiratory tract infection and discharged to home (with or without a short stay in a skilled nursing facility prior to going home): structured telephone support (STS); low-intensity remote patient monitoring (RPM-Low); and high-intensity remote patient monitoring (RPM-High). The remote patient monitoring models will be staffed by a physician or a nurse (Standard Team) or by a dedicated nurse-practitioner (NP)-led multidisciplinary team (Enhanced Team). Patients will be randomized to one of five arms: STS, RPM-Low + Standard Team, RPM-Low + Enhanced Team, RPM-High + Standard Team, and RPM-High + Enhanced Team. Using response adaptive randomization (RAR), interim outcome results will be used to modify the random allocation of patients to each study arm. The primary outcome is number of days spent at home within 90 days after hospital discharge. Patient-reported functional status and quality of life data will be collected in addition to electronic health record (EHR) and claims-based data to measure health care utilization. Qualitative interviews with patients and providers will provide insight into the effectiveness of the implementation process.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1288
Inclusion Criteria
  • UPMC Health Plan members
  • Medicare Fee-for-Service enrollees
  • Age 21+ -Hospitalized with a primary diagnosis of sepsis or lower respiratory tract infection, --
  • Discharged to home, independent living facility, or skilled nursing facility
  • Readmission risk is moderate or high
Exclusion Criteria
  • Admitted from hospice;
  • Discharged to hospice, inpatient rehabilitation, or a long term acute care facility;
  • Known to be pregnant;
  • Current enrollment in another remote patient monitoring program;
  • Failure of the Callahan 6 item cognitive screen and do not have a proxy to consent;
  • No access to a technological device required to participate in remote patient monitoring program;
  • Current enrollment in UPMC Advanced Illness Care program;
  • Severe, persistent cognitive impairment;
  • No documented PCP;
  • PCP disapproves of the patient being enrolled in remote patient monitoring;
  • Discharged from hospital to skilled nursing facility and stay at the skilled nursing facility for greater than 28 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Post-discharge home days90 days after discharge to home

days alive and at home

Secondary Outcome Measures
NameTimeMethod
Mortalitymeasured at 90 days

Mortality will be assessed via claims data to see if and when the member/participant passes away.

Functional Status (measured by PROMIS Physical Function-for Mobility Aid Users-SF)baseline, 90 days

Functional Status will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function - for Mobility Aid Users-SF. This measures one's ability to stand, walk, and perform activities of daily living if some participants utilize mobility aids such as wheelchairs. The minimum score for patients who can walk 25 feet is 11 and the maximum 55. The minimum score for patients who cannot walk 25 feet is 8 and the maximum score is 40. Higher scores indicate better function status for both groups.

Transition to Hospicemeasured at 90 days after discharge to home

Transition to Hospice will be assessed via health insurance claims.

Health-related Quality of Life (measured by Quality of Life Enjoyment and Satisfaction Questionnaire-SF)baseline, 90 days

Health-related Quality of Life will be measured using the Quality of Life Enjoyment and Satisfaction Questionnaire-SF. The Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) is a self-report measure designed to enable investigators to easily obtain sensitive measures of the degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning. The Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF) is a 16 item self-administered questionnaire that captures life satisfaction over the past week. Each question is rated on a 5 point scale from 1 (Very Poor) to 5 (Very Good). A total score is derived from 14 items with a maximum score of 70 and with higher scores indicating greater life satisfaction and enjoyment.

Emergent outpatient utilizationmeasured at 90 days after discharge to home

Emergent outpatient utilization includes emergency department visits and urgent care visits. It will be assessed via claims data at 90 days for study participants.

Hospital readmissionsmeasured at 90 days

Readmissions will be assessed via health insurance claims for any inpatient admissions after index admission.

Trial Locations

Locations (1)

UPMC Presbyterian

🇺🇸

Pittsburgh, Pennsylvania, United States

UPMC Presbyterian
🇺🇸Pittsburgh, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.